A Psychedelic and Cannabis Research Revolution On the Horizon?

A Psychedelic and Cannabis Research Revolution On the Horizon?

Author: Cannabis Radio April 22, 2026 Duration: 29:28

This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental health disorders.

The newly signed executive order to direct the FDA to fast-track these compounds through new "National Priority" vouchers.

Beyond psychedelics, the host discusses the impact of GLP-1 weight-loss drugs (like Ozempic) on the cannabis market, noting that dispensaries are seeing a shift in consumer preference toward lower-dose products to mitigate "the munchies."



Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

There’s a lot more to the cannabis industry than what grows in the field. Blunt Business, from Cannabis Radio, digs into the complex reality of building and running a company in this fast-moving space. We’re talking about the real work behind the scenes-supply chain logistics, regulatory hurdles, branding in a crowded market, and managing teams in a unique cultural environment. Each episode brings together voices who are actually doing the job, from executives steering multi-state operations to entrepreneurs who just opened their first dispensary. You’ll hear candid roundtable discussions where strategies are debated, and interviews that get into the specifics of leadership and finance without the hype. This isn’t about advocacy or culture; it’s a practical look at the mechanics of a profitable, high-stakes business. Tune in for a podcast that cuts through the smoke and offers tangible insights you can apply, whether you’re an investor, a manager, or building your own venture from the ground up.
Author: Language: English Episodes: 100

Blunt Business
Podcast Episodes
Cannabis Industry Turbulence: Banking, Reform, and Future Strategies [not-audio_url] [/not-audio_url]

Duration: 45:45
Blunt Business welcomes back Jonathan Robbins, head of the cannabis practice at Akerman, to talk about the cannabis industry's persistent hurdles, encompassing federal reform, banking complexities, and state-federal law…
Regulatory Storms and Big Brand Retail Realities in NYC [not-audio_url] [/not-audio_url]

Duration: 39:24
Blunt Business explores the complexities of New York's nascent legal cannabis market through a conversation with Joshua Wilson, the general manager of Culture House, a dispensary located in the heart of Midtown Manhattan…
Goldenhour Collective: Navigating the Evolving Cannabis Landscape [not-audio_url] [/not-audio_url]

Duration: 34:16
This interview with David Spradlin from Goldenhour Collective provides a comprehensive overview of the evolving cannabis industry, focusing on the challenges and opportunities presented by its transition from a patient-c…
The INCBA's Perspective on Regulation, Compliance, and Investment [not-audio_url] [/not-audio_url]

Duration: 43:47
Blunt Business explores the critical issues facing the cannabis industry, focusing on regulation, compliance, and investment, through the lens of the International Cannabis Bar Association (INCBA). David Ruskin, their ne…